BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17766597)

  • 1. Breast cancer screening for women 40 to 49 years of age: what is a clinician to do?
    Gemignani ML
    Obstet Gynecol; 2007 Sep; 110(3):548-9. PubMed ID: 17766597
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening and prevention of breast cancer in primary care.
    Tice JA; Kerlikowske K
    Prim Care; 2009 Sep; 36(3):533-58. PubMed ID: 19616154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population screening for breast cancer by mammography in The Netherlands. Expectations, early results, negative effects and conditions for large-scale screening.
    Hendriks JH; Verbeek AL
    Diagn Imaging Clin Med; 1985; 54(3-4):186-91. PubMed ID: 3896616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mass screening for breast cancer: remaining questions].
    Verbeek AL
    Ned Tijdschr Geneeskd; 1987 Sep; 131(37):1602-4. PubMed ID: 3670448
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for breast cancer in India--is it an appropriate strategy?
    Moss S
    J Natl Cancer Inst; 2008 Sep; 100(18):1270-1. PubMed ID: 18780862
    [No Abstract]   [Full Text] [Related]  

  • 6. Are there downsides to mammography screening?
    Baines CJ
    Breast J; 2005; 11 Suppl 1():S7-10. PubMed ID: 15725116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting the risk of a false-positive test for women following a mammography screening programme.
    Njor SH; Olsen AH; Schwartz W; Vejborg I; Lynge E
    J Med Screen; 2007; 14(2):94-7. PubMed ID: 17626709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk benefit in mass screening programs for breast cancer.
    Miller AB
    Semin Oncol; 1978 Dec; 5(4):351-9. PubMed ID: 104389
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mammography screening: presentation of scientific evidence as a basis for communication with women].
    Mühlhauser I; Höldke B
    Z Arztl Fortbild Qualitatssich; 2000 Oct; 94(9):721-31. PubMed ID: 11127779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cancer screening: medico-legal aspects].
    Buzzi F
    Ann Ig; 2003; 15(1):3-10. PubMed ID: 12666320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychological consequences of breast cancer screening among healthy women].
    von Bülow B
    Ugeskr Laeger; 2000 Feb; 162(8):1053-9. PubMed ID: 10741242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of clinical breast examination to the accuracy of breast screening.
    Chiarelli AM; Majpruz V; Brown P; Thériault M; Shumak R; Mai V
    J Natl Cancer Inst; 2009 Sep; 101(18):1236-43. PubMed ID: 19720967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mass screening of cancer of the breast: politico-economic objectives and their underestimated risks].
    Dilhuydy MH
    Contracept Fertil Sex; 1998 Jun; 26(6):420-4. PubMed ID: 9691519
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed benefit of mammography screening in premenopausal women.
    Jatoi I; Soballe PW; Anderson WF
    J Clin Oncol; 2004 Dec; 22(23):4860; author reply 4860-2. PubMed ID: 15570095
    [No Abstract]   [Full Text] [Related]  

  • 15. MRI screening in a clinic population with a family history of breast cancer.
    Yu J; Park A; Morris E; Liberman L; Borgen PI; King TA
    Ann Surg Oncol; 2008 Feb; 15(2):452-61. PubMed ID: 18026801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of participation on the cumulative risk of false-positive recall in a breast cancer screening programme.
    Molins E; Comas M; Román R; Rodríguez-Blanco T; Sala M; Macià F; Murta-Nascimento C; Castells X
    Public Health; 2009 Sep; 123(9):635-7. PubMed ID: 19733372
    [No Abstract]   [Full Text] [Related]  

  • 17. [Systematic screening of breast cancer after fifty: an arbitrary limit?].
    Sancho-Garnier H
    Gynecol Obstet Fertil; 2004; 32(7-8):664-8. PubMed ID: 15450268
    [No Abstract]   [Full Text] [Related]  

  • 18. Participation behaviour following a false positive test in the Copenhagen mammography screening programme.
    Andersen SB; Vejborg I; von Euler-Chelpin M
    Acta Oncol; 2008; 47(4):550-5. PubMed ID: 18465321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Breast cancer screening is efficient and useful from the age of forty].
    Tristant H
    Gynecol Obstet Fertil; 2004; 32(7-8):659-63. PubMed ID: 15450267
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular subtypes of breast cancers detected in mammography screening and outside of screening.
    Sihto H; Lundin J; Lehtimäki T; Sarlomo-Rikala M; Bützow R; Holli K; Sailas L; Kataja V; Lundin M; Turpeenniemi-Hujanen T; Isola J; Heikkilä P; Joensuu H
    Clin Cancer Res; 2008 Jul; 14(13):4103-10. PubMed ID: 18593987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.